Improving methods of clinical practice guidelines: From guidelines to pathways to fast‐and‐frugal trees and decision analysis to develop individualised patient care

Abstract

BackgroundCurrent methods for developing clinical practice guidelines have several limitations: they are characterised by the “black box” operation—a process with defined inputs and outputs but an incomplete understanding of its internal workings; they have “the integration problem”—a lack of framework for explicitly integrating factors such as patient preferences and trade‐offs between benefits and harms; they generate one recommendation at a time that typically are not connected in a coherent analytical framework; and they apply to “average” patients, while clinicians and their patients seek advice tailored to individual circumstances.MethodsWe propose augmenting the current guideline development method by converting evidence‐based pathways into fast‐and‐frugal decision trees (FFTs) and integrating them with generalised decision curve analysis to formulate clear, individualised management recommendations.ResultsWe illustrate the process by developing recommendations for the management of heparin‐induced thrombocytopenia (HIT). We converted evidence‐based pathways for HIT, developed by the American Society of Hematology, into an FFT. Here, we consider only thrombotic complications and major bleeding. We leveraged the predictive potential of FFTs to compare the effects of argatroban, bivalirudin, fondaparinux, and direct oral anticoagulants (DOACs) using generalised decision curve analysis. We found that DOACs were superior to other treatments if the FFT‐predicted probability of HIT exceeded 3%.ConclusionsThe proposed analytical framework connects guidelines, pathways, FFTs, and decision analysis, offering risk‐tailored personalised recommendations and addressing current guideline development critiques.